Financing Instruments
As described above, the core
financing instruments are the long-term loans of € 500 million as well
as the credit facility of € 300 million. Of this, € 150 million can be
used for acquisition purposes; as of December 31, this amount is fully
available. In order to tap new sources of credit, reflecting the
company’s position as an MDAX listed company, financing needs may be
funded more through capital market instruments such as bonds, private
placements, or similar instruments, as appropriate.
In addition, Symrise uses derivative financial instruments for controlling its interest and foreign exchange result.